Back
Citius Oncology, Inc. Stock Price Chart
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
20
CTOR
Citius Oncology, Inc.
Last Price:
$1.11
Seasonality Move:
0.9%
7 Day Trial
ALL ACCESS PASS
$
7
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTOR is experiencing slight selling pressure.
Citius Oncology, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.28 | Sell |
| 20-day SMA: | 1.29 | Sell |
| 50-day SMA: | 1.58 | Sell |
| 200-day SMA: | 1.54 | Sell |
| 8-day EMA: | 1.26 | Sell |
| 20-day EMA: | 1.33 | Sell |
| 50-day EMA: | 1.51 | Sell |
| 200-day EMA: | 2.01 | Sell |
Citius Oncology, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 38.26 | Sell |
| Chaikin Money Flow: | -1057855 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.17 - 1.55) | Sell |
| Bollinger Bands (100): | (1.45 - 1.97) | Sell |
Citius Oncology, Inc. Technical Analysis
| Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Citius Oncology, Inc. Stock
Is Citius Oncology, Inc. Stock a Buy?
-
Citius Oncology, Inc. share price is 1.11 while CTOR 8-day simple moving average is 1.28, which is a Sell signal.
-
The stock price of CTOR is 1.11 while Citius Oncology, Inc. 20-day SMA is 1.29, which makes it a Sell.
-
Citius Oncology, Inc. 50-day simple moving average is 1.58 while CTOR share price is 1.11, making it a Sell technically.
-
CTOR stock price is 1.11 and Citius Oncology, Inc. 200-day simple moving average is 1.54, creating a Sell signal.
CTOR Technical Analysis vs Fundamental Analysis
Sell
20
Citius Oncology, Inc. (CTOR)
is a Sell
Is Citius Oncology, Inc. a Buy or a Sell?
-
Citius Oncology, Inc. stock is rated a SellThe current Citius Oncology, Inc. [CTOR] share price is $1.11. The Score for CTOR is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Citius Oncology, Inc. Stock Info
Market Cap:
87M
Price in USD:
1.11
Share Volume:
2.1M
Citius Oncology, Inc. 52-Week Range
52-Week High:
6.19
52-Week Low:
0.55
Sell
20
Citius Oncology, Inc. (CTOR)
is a Sell
Citius Oncology, Inc. Share Price Forecast
-
What is the Citius Oncology, Inc. stock price today?The Citius Oncology, Inc. stock price is 1.11 USD today.
-
Will CTOR stock go up or go down?Citius Oncology, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Citius Oncology, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Citius Oncology, Inc. is overvalued.
Is Citius Oncology, Inc. Stock a Buy?
-
Citius Oncology, Inc. share price is 1.11 while CTOR 8-day exponential moving average is 1.26, which is a Sell signal.
-
The stock price of CTOR is 1.11 while Citius Oncology, Inc. 20-day EMA is 1.33, which makes it a Sell.
-
Citius Oncology, Inc. 50-day exponential moving average is 1.51 while CTOR share price is 1.11, making it a Sell technically.
-
CTOR stock price is 1.11 and Citius Oncology, Inc. 200-day simple moving average is 2.01, creating a Sell signal.
Technical Analysis of Citius Oncology, Inc.
Should I short Citius Oncology, Inc. stock?
-
CTOR Moving Average Covergence Divergence (MACD) indicator is -0.09, suggesting Citius Oncology, Inc. is a Sell
-
Citius Oncology, Inc. Relative Strength Index (RSI) is 38.26, which suggest Citius Oncology, Inc. is oversold
-
The Bollinger Bands (25) for Citius Oncology, Inc. is (1.17 - 1.55), which suggest Citius Oncology, Inc. is a Sell
-
The Bollinger Bands (100) for Citius Oncology, Inc. is (1.45 - 1.97), which suggest Citius Oncology, Inc. is a Sell
* Citius Oncology, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.